RCE 1.75% 58.0¢ recce pharmaceuticals ltd

Ann: Update on Phase I/II Clinical Trial for Burn Wound Infection, page-104

  1. 5,252 Posts.
    lightbulb Created with Sketch. 679
    I meant "maybe Fiona Stanley are so impressed with phase 2 they will push for next phase asap due to unmet need."

    It would also be valuable I think if Recce refer directly to the QIDP and or FDA regarding future progress or plans at some stage.

    Hard to believe they just plan to sell this product in Australia but would be good to get official confirmation FDA is a target for either or both IV and burns? At this stage there still appear to be some who think they have decided against this path.
    I'm looking forward to seeing where this goes .
    Last edited by andrewk65: 07/01/22
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
58.0¢
Change
0.010(1.75%)
Mkt cap ! $118.3M
Open High Low Value Volume
59.3¢ 60.0¢ 57.0¢ $118.9K 208.4K

Buyers (Bids)

No. Vol. Price($)
1 999 58.0¢
 

Sellers (Offers)

Price($) Vol. No.
60.0¢ 158533 1
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
59.0¢
  Change
0.010 ( 2.61 %)
Open High Low Volume
57.5¢ 59.0¢ 57.0¢ 35799
Last updated 13.50pm 28/05/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.